This paper is in the following e-collection/theme issue:

Telehealth and Telemonitoring (2085) Substance Abuse (530) Opioid and Related Substance Misuse (200) Infectious Diseases (non-STD/STI) (1725) Focus Groups and Qualitative Research for Human Factors Research (1218) mHealth in the Developing World/LMICs, Underserved Communities, and for Global Health (717) Knowledge Translation and Implementation Science (513)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53049, first published .
Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study

Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study

Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study

Authors of this article:

Suzanne S Dickerson1 Author Orcid Image ;   Saliyah J George2 Author Orcid Image ;   Ana Ventuneac3 Author Orcid Image ;   Arpan Dharia4 Author Orcid Image ;   Andrew H Talal4 Author Orcid Image
Article Authors Cited by (7) Tweetations (4) Metrics

Journals

  1. Papalamprakopoulou Z, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Dickerson S, Hatzakis A, Talal A. Breaking the vicious cycle of delayed healthcare seeking for people who use drugs. Harm Reduction Journal 2025;22(1) View
  2. Finbråten A, Chin C, Seetharaman M, Hutchings K, Eckhardt B, Schackman B, Kapadia S. Providers’ Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study. Open Forum Infectious Diseases 2025;12(4) View
  3. Talal A, Dharia A, Markatou M, Brown Jr L, Bossert K, Grubbs Z, Mukhopadhyay R, Ntiri-Reid B, Houtsmuller E. Facilitated Telemedicine as a Patient-Centered, Sociotechnical Intervention to Integrate Hepatitis C Treatment Into Opioid Treatment Programs and Overcome the Digital Divide Among Underserved Populations: Qualitative Study. JMIR Public Health and Surveillance 2025;11:e68854 View
  4. Bredenberg E, Callister C, Dafoe A, Holliman B, Rowan S, Calcaterra S. Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators. Journal of Hospital Medicine 2025;20(12):1323 View
  5. Papalamprakopoulou Z, Dang T, Gonzalez C, Tedesco C, Updike P, Corl C, Dharia A, Hernandez N, Shapiro M, Wethington E, Talal A. Long‐Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response. Health Expectations 2025;28(5) View
  6. Gonzalez C, Perez‐Mejia C, Hernandez N, Kapadia S, Niederdeppe J, Dharia A, Papalamprakopoulou Z, Talal A, Lloyd A, Franco R, Shapiro M, Wethington E. Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties. Journal of Viral Hepatitis 2025;32(11) View
  7. Talal A, Markatou M, Zeremski M, Liu A, Dharia A, George S, Taylor M, Davis K, Silber A, Brown L, Tobin J. Opioid treatment program-integrated facilitated telemedicine for hepatitis C treatment: a hybrid effectiveness-implementation analysis. BMC Complementary Medicine and Therapies 2025;25(1) View